Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1759752

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1759752

Global Home Healthcare Market - Forecast & Opportunity 2025-2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2990
PDF (5 User License + Excel)
USD 3490
PDF (Corporate License)
USD 3990

Add to Cart

Home Healthcare Market Trends, Size & Forecast 2025-2033 | Renub Research

Home Healthcare Market is expected to reach US$ 777.46 billion by 2033 from US$ 382.5 billion in 2024, with a CAGR of 8.20% from 2025 to 2033. An aging population, rising cases of chronic diseases, technology advancements, the desire for cost-effective care, and enhanced demand for customized in-home services are the primary drivers driving the home healthcare market. Regional market growth and uptake are complemented by positive government policies and increased awareness.

Global Home Healthcare Market Report by Component (Services, Equipment), Indication (Neurological & Mental Disorders, Diabetes & Kidney Disorders, Cancer, Respiratory Disease & COPD, Mobility Disorders, Cardiovascular Disorder & Hypertension, Wound Care, Maternal Disorders, Others), Countries and Company Analysis 2025-2033.

Global Home Healthcare Industry Overview

Medical and non-medical care provided in a patient's dwelling to maintain, improve, or enhance health and well-being is known as home healthcare. Individuals with disabilities, chronic conditions, the aging, and individuals recovering from surgery or hospitalization often use it. Physical therapy, occupational therapy, speech therapy, professional nursing, and assistance with daily activities such as cooking or bathing are some of the services provided. Home care lowers the demand for prolonged institutionalization and hospitalization by offering personalized, low-cost care. It allows for family involvement while enhancing patient comfort and autonomy. Improved technology has also enabled remote patient monitoring and virtual consultation, which has enhanced access to and the quality of care.

The worldwide home healthcare market is being spurred on by the increasing population of elderly people, who require ongoing medical treatment and assistance, particularly for long-term diseases. In 2024, 10% of the world's population would be 65 years or older, as estimated by the Population Reference Bureau (PRB). Further, individuals are opting for more cost-effective in-home care due to the increased costs of healthcare. Home healthcare is becoming more efficient and accessible due to technological advances such as telemedicine and remote patient monitoring. Demand is also increased due to the growing awareness of the benefits of personalized care, including increased comfort and autonomy. The market is also fueled by favoring government policies, healthcare reforms, and the increasing availability of insurance coverage for home healthcare services, making it a more attractive option for patients globally.

Growth Drivers for the Home Healthcare Market

Favorable Government initiatives

Government programs are transforming the potential benefits of home care and passing legislation to promote its use, particularly for older adults. Columbia's health minister, for instance, extended programs to allow more elderly people to remain at home in March 2024 by investing more than USD 354 million in cash over a period of three years. To support elders and reduce the burden on medical facilities and long-term care centers, the initiative would improve home health services from regional health authorities and community-based senior services from nonprofit organizations. To treat chronic diseases without frequent hospital stays, monitor patients from afar, and facilitate virtual consultations, a number of governments also promote the utilization of telehealth technologies and remote monitoring equipment. For instance, the government of Uttar Pradesh launched the 'Digital Doctor Initiative' in October 2023 with an aim to enhance the state's access to medical care. Moreover, it will integrate telemedicine with on-the-spot basic diagnostic capabilities. Apart from this, home healthcare market share is also being supported by research and development (R&D) investments in efforts aimed at improving the provision of healthcare in the home, such as wearable technology, remote monitoring systems, and electronic health records.

Chronic illness prevalence

Home healthcare is being driven by the rising number of cases of diabetes, heart disease, chronic respiratory conditions, and neurological conditions. The Centers for Disease Control and Prevention have estimated that cardiovascular disease will take one life every 33 seconds in 2024. Furthermore, the New York State Department of Health states that in 2021, cardiovascular disease, or CVD, accounted for 27% of all state deaths. The market is spurred due to the fact that these diseases often require constant management, frequent monitoring, and personalized care. Furthermore, since patients with chronic conditions are often required to have follow-up visits, hospital readmissions, and ongoing care, the adoption of remote monitoring will reduce hospital and healthcare facility burdens, thus increasing market growth. For example, in March 2024, mobile health technology firm UTMHealthcare partnered with Somml Health, a virtual care platform, to launch NuLink Health, which collaborates with physicians to treat vulnerable patients more effectively between appointments, saving medical practices effort and money. To equip patients with chronic, complicated conditions with optimal care and reduce hospital readmission, it utilizes Somml Health's virtual care solution and UTMHealthcare's remote patient monitoring (RPM) system. Moreover, the future of home healthcare market is being fueled by being able to better serve healthcare resources for patients with acute and critical illnesses by giving them care at home.

Growing use of cutting-edge technologies

Home healthcare is on the rise largely because of advancements in technology. Medical devices and sensors allow health workers to monitor patients' vital signs, health parameters, and adherence to treatment regimens from afar. For instance, the leading clinical patient monitoring software and viQtor, smartQare's innovative offering, were combined in April 2024 by Royal Philips, a leading health tech company. The next wave of continuous monitoring, both within and outside hospitals, will be brought to patients across Europe by this partnership. Furthermore, improvements in wearable devices, electronic health records (EHRs), telemedicine, and remote monitoring devices are transforming home healthcare. Examples include Pylo Health, a remote patient monitoring equipment provider, which rolled out two cutting-edge patient devices in January 2024: the Pylo 900-LTE blood pressure monitor and Pylo 200-LTE weight scale, for patients who are enrolled in remote patient monitoring (RPM) programs for hypertension and attendant chronic conditions. With its mobile 4G/5G connectivity and 2G fallback, the blood pressure monitor connects patients even in remote regions with poor accessibility. By providing timely interventions, allowing real-time monitoring of vital signs, and enhancing the communication between patients and healthcare professionals, these technologies save healthcare expenditures and improve patient outcomes.

Challenges in the Home Healthcare Market

Regulatory and Compliance Issues

In the market for home healthcare, regulatory and compliance concerns present major obstacles. Healthcare legislation like HIPAA, accreditation standards, and licensing criteria are just a few of the complicated and regionally specific rules that providers must deal with. Operational expenses rise as a result of the significant administrative resources and continuous employee training required to comply with these regulations. Regulations that change frequently can cause misunderstandings and interfere with the provision of services. Non-compliance also runs the danger of losing funds or accreditation, facing legal repercussions, and harming one's reputation. Managing these criteria can be especially difficult for smaller agencies, which restricts their capacity to grow. One of the biggest challenges facing the sector is continuing to provide high-quality treatment while adhering to regulations.

Reimbursement and Funding

Funding and reimbursement represent some of the biggest obstacles in the home healthcare industry. Inconsistent reimbursement regulations, complicated billing processes, and limited insurance coverage make it challenging for clinicians to get paid on time and in full. Strict eligibility requirements and low payment rates are common features of government programs like Medicare and Medicaid, which have an impact on service affordability and provider sustainability. These budgetary limitations may discourage investment in home healthcare services and restrict patient access, especially for those living in rural or low-income areas, which would impede the expansion of the market as a whole.

United States Home Healthcare Market

Changes in legislation and technology are driving the fast evolution of the home healthcare business in the United States. To monitor the use of telecommunications technology in home healthcare services, the Centers for Medicare & Medicaid Services (CMS) implemented three new codes in January 2023. By standardizing the reporting of remote patient monitoring and telemedicine, these codes hope to enhance the quality of care. In January 2023, musculoskeletal service provider Hinge Health also included a house call physical therapy service to its list of offerings. This service represents the growing trend toward individualized, tech-driven home healthcare solutions by combining digital care with in-person examinations, improving accessibility and patient participation.

India Home Healthcare Market

An aging population, a rise in chronic illnesses, and technological improvements are driving the rapid growth of the home healthcare industry in India. Hospital visits are being decreased and home care services are being promoted by government programs like the Ayushman Bharat Scheme. Healthcare is now more accessible because to the growth of telemedicine, particularly in rural areas. Digital tactics and investments from the business sector are also enhancing patient engagement, operational effectiveness, and service delivery. These elements are driving the growth of the home healthcare market in India, as are growing healthcare awareness and the need for reasonably priced care.

United Kingdom Home Healthcare Market

An aging population, an increase in chronic illnesses, and a growing need for in-home care are all driving growth in the UK home healthcare sector. Long-term care residents were the focus of Nurseplus's 'Care at Home' service, which was introduced in Aylesbury in December 2022 by the UK-based nursing and care services company. With options for daily, weekly, or live-in care, this service provides patients with individualized care plans that guarantee high-quality, compliant support. Offering a more comfortable and adaptable option to traditional healthcare venues, the industry is expanding due in large part to the increased preference for home-based care, technological developments, and a shift toward more tailored services.

United Arab Emirates Home Healthcare Market

An aging population, an increase in chronic illnesses, and a growing need for individualized care are driving the United Arab Emirates' (UAE) home healthcare market's rapid growth. Manzil Healthcare Services and Spectator Healthcare Technology established a strategic partnership in October 2024 with the goal of using tech-enabled solutions to revolutionize healthcare delivery in Saudi Arabia, the United Arab Emirates, and Qatar. With a network of more than 360 healthcare providers, Manzil offers a variety of medical services at patients' doorsteps, including elder care, medicinal infusions, and postnatal care, all of which are backed by cutting-edge technology. In line with the larger trend toward individualized, tech-driven home healthcare services, this collaboration seeks to improve healthcare accessibility and efficiency in the area.

Home Healthcare Market Segments:

Component

  • Services
  • Equipment

Indication

  • Neurological & Mental Disorders
  • Diabetes & Kidney Disorders
  • Cancer
  • Respiratory Disease & COPD
  • Mobility Disorders
  • Cardiovascular Disorder & Hypertension
  • Wound Care
  • Maternal Disorders
  • Others

Country - Market breakup in 25 viewpoints:

North America

  • United States
  • Canada

Europe

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Turkey

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • New Zealand

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • United Arab Emirates

All companies have been covered from 4 viewpoints:

  • Company Overview
  • Key Persons
  • Recent Development & Strategies
  • Sales Analysis

Key Players Analysis

  • 3M Healthcare
  • Apple Inc.
  • Arkray, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson And Company
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co KGaA
  • Hollister Inc.

Table of Contents

1. Introduction

2. Research Methodology

  • 2.1 Data Source
    • 2.1.1 Primary Sources
    • 2.1.2 Secondary Sources
  • 2.2 Research Approach
    • 2.2.1 Top-Down Approach
    • 2.2.2 Bottom-Up Approach
  • 2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Home Healthcare Market

  • 5.1 Historical Market Trends
  • 5.2 Market Forecast

6. Home Healthcare Market Share Analysis

  • 6.1 By Component
  • 6.2 By Indication
  • 6.3 By Countries

7. Component

  • 7.1 Services
  • 7.2 Equipment

8. Indication

  • 8.1 Neurological & Mental Disorders
  • 8.2 Diabetes & Kidney Disorders
  • 8.3 Cancer
  • 8.4 Respiratory Disease & COPD
  • 8.5 Mobility Disorders
  • 8.6 Cardiovascular Disorder & Hypertension
  • 8.7 Wound Care
  • 8.8 Maternal Disorders
  • 8.9 Others

9. Countries

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
  • 9.2 Europe
    • 9.2.1 France
    • 9.2.2 Germany
    • 9.2.3 Italy
    • 9.2.4 Spain
    • 9.2.5 United Kingdom
    • 9.2.6 Belgium
    • 9.2.7 Netherlands
    • 9.2.8 Turkey
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Thailand
    • 9.3.6 Malaysia
    • 9.3.7 Indonesia
    • 9.3.8 Australia
    • 9.3.9 New Zealand
  • 9.4 Latin America
    • 9.4.1 Brazil
    • 9.4.2 Mexico
    • 9.4.3 Argentina
  • 9.5 Middle East & Africa
    • 9.5.1 Saudi Arabia
    • 9.5.2 UAE
    • 9.5.3 South Africa

10. Porter's Five Forces Analysis

  • 10.1 Bargaining Power of Buyers
  • 10.2 Bargaining Power of Suppliers
  • 10.3 Degree of Rivalry
  • 10.4 Threat of New Entrants
  • 10.5 Threat of Substitutes

11. SWOT Analysis

  • 11.1 Strength
  • 11.2 Weakness
  • 11.3 Opportunity
  • 11.4 Threat

12. Key Players Analysis

  • 12.1 3M Healthcare
    • 12.1.1 Overview
    • 12.1.2 Key Persons
    • 12.1.3 Recent Development & Strategies
    • 12.1.4 Revenue Analysis
  • 12.2 Apple Inc.
    • 12.2.1 Overview
    • 12.2.2 Key Persons
    • 12.2.3 Recent Development & Strategies
    • 12.2.4 Revenue Analysis
  • 12.3 Arkray, Inc.
    • 12.3.1 Overview
    • 12.3.2 Key Persons
    • 12.3.3 Recent Development & Strategies
    • 12.3.4 Revenue Analysis
  • 12.4 B. Braun Melsungen AG
    • 12.4.1 Overview
    • 12.4.2 Key Persons
    • 12.4.3 Recent Development & Strategies
    • 12.4.4 Revenue Analysis
  • 12.5 Becton, Dickinson And Company
    • 12.5.1 Overview
    • 12.5.2 Key Persons
    • 12.5.3 Recent Development & Strategies
    • 12.5.4 Revenue Analysis
  • 12.6 F. Hoffmann-La Roche AG
    • 12.6.1 Overview
    • 12.6.2 Key Persons
    • 12.6.3 Recent Development & Strategies
    • 12.6.4 Revenue Analysis
  • 12.7 Fresenius SE & Co KGaA
    • 12.7.1 Overview
    • 12.7.2 Key Persons
    • 12.7.3 Recent Development & Strategies
    • 12.7.4 Revenue Analysis
  • 12.8 Hollister Inc.
    • 12.8.1 Overview
    • 12.8.2 Key Persons
    • 12.8.3 Recent Development & Strategies
    • 12.8.4 Revenue Analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!